Several industry players have established peptide manufacturing facilities across the world.
During our research, we came across North America and Europe emerged as the current manufacturing hub for peptides, as 75% of the total facilities are presently located in these regions.
Various companies were found to be involved in the manufacturing of peptide APIs, while few were focused on the manufacturing of peptide FDF.
Our analysis also revealed that, some of the companies were involved in the manufacturing of both peptide API and FDF in the same facility.
The key observations on the location of the manufacturing facility have been highlighted below:In North America, the US has emerged as the key hub for peptide manufacturing.
Examples of players that have manufacturing facilities in the US include (in alphabetical order) Karebay Biochem, Peptide Institute, PolyPeptide and Sekisui Xenotech.Within Europe, the UK (22%) and Switzerland (17%) emerged as the key peptide manufacturing hubs.
Several industry players have established peptide manufacturing facilities across the world.
During our research, we came across North America and Europe emerged as the current manufacturing hub for peptides, as 75% of the total facilities are presently located in these regions.
Various companies were found to be involved in the manufacturing of peptide APIs, while few were focused on the manufacturing of peptide FDF.
Our analysis also revealed that, some of the companies were involved in the manufacturing of both peptide API and FDF in the same facility.
The key observations on the location of the manufacturing facility have been highlighted below:In North America, the US has emerged as the key hub for peptide manufacturing.
Examples of players that have manufacturing facilities in the US include (in alphabetical order) Karebay Biochem, Peptide Institute, PolyPeptide and Sekisui Xenotech.Within Europe, the UK (22%) and Switzerland (17%) emerged as the key peptide manufacturing hubs.